A Randomized, Multicenter, Controlled Study of XELOX (Oxaliplatin With Capecitabine) Combined With Apatinib Versus XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma With D2 Dissection.
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Rivoceranib (Primary) ; Capecitabine; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 30 Nov 2017 New trial record